These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 34112520

  • 1. Frequently Reported Adverse Events With Smoking Cessation Medications: Post Hoc Analysis of a Randomized Trial.
    Ebbert J, Jimenez-Ruiz C, Dutro MP, Fisher M, Li J, Hays JT.
    Mayo Clin Proc; 2021 Jul; 96(7):1801-1811. PubMed ID: 34112520
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.
    Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, Ascher J, Russ C, Krishen A, Evins AE.
    Lancet; 2016 Jun 18; 387(10037):2507-20. PubMed ID: 27116918
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial.
    Evins AE, Benowitz NL, West R, Russ C, McRae T, Lawrence D, Krishen A, St Aubin L, Maravic MC, Anthenelli RM.
    J Clin Psychopharmacol; 2019 Jun 18; 39(2):108-116. PubMed ID: 30811371
    [Abstract] [Full Text] [Related]

  • 6. Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial.
    Nollen NL, Ahluwalia JS, Sanderson Cox L, Okuyemi K, Lawrence D, Samuels L, Benowitz NL.
    JAMA Netw Open; 2021 Jan 04; 4(1):e2032053. PubMed ID: 33464316
    [Abstract] [Full Text] [Related]

  • 7. Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors.
    Beard E, Jackson SE, Anthenelli RM, Benowitz NL, Aubin LS, McRae T, Lawrence D, Russ C, Krishen A, Evins AE, West R.
    Addiction; 2021 Oct 04; 116(10):2816-2824. PubMed ID: 33885203
    [Abstract] [Full Text] [Related]

  • 8. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB, Piper ME, Stein JH, Smith SS, Bolt DM, Fraser DL, Fiore MC.
    JAMA; 2016 Jan 26; 315(4):371-9. PubMed ID: 26813210
    [Abstract] [Full Text] [Related]

  • 9. The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial.
    Cinciripini PM, Kypriotakis G, Green C, Lawrence D, Anthenelli RM, Minnix J, Blalock JA, Beneventi D, Morris C, Karam-Hage M.
    Depress Anxiety; 2022 May 26; 39(5):429-440. PubMed ID: 35535436
    [Abstract] [Full Text] [Related]

  • 10. Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial.
    Park ER, Perez GK, Regan S, Muzikansky A, Levy DE, Temel JS, Rigotti NA, Pirl WF, Irwin KE, Partridge AH, Cooley ME, Friedman ER, Rabin J, Ponzani C, Hyland KA, Holland S, Borderud S, Sprunck K, Kwon D, Peterson L, Miller-Sobel J, Gonzalez I, Whitlock CW, Malloy L, de León-Sanchez S, O'Brien M, Ostroff JS.
    JAMA; 2020 Oct 13; 324(14):1406-1418. PubMed ID: 33048154
    [Abstract] [Full Text] [Related]

  • 11. Pharmacovigilance Assessment of Cardiac Implications of Nicotine Replacement Therapy Among Smokers.
    Olawuyi O, Mathieson K.
    Curr Drug Saf; 2020 Oct 13; 15(3):173-180. PubMed ID: 32525783
    [Abstract] [Full Text] [Related]

  • 12. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE, Pipe AL, Els C, Clyde MJ, Reid RD.
    BMC Med; 2016 Jun 07; 14():80. PubMed ID: 27233840
    [Abstract] [Full Text] [Related]

  • 13. Smoking Cessation Pharmacotherapy Efficacy in Comorbid Medical Populations: Secondary Analysis of the Evaluating Adverse Events in a Global Smoking Cessation Study (EAGLES) Randomized Clinical Trial.
    Rojewski AM, Palmer AM, Baker NL, Toll BA.
    Nicotine Tob Res; 2024 Jan 01; 26(1):31-38. PubMed ID: 37474127
    [Abstract] [Full Text] [Related]

  • 14. Nicotine receptor partial agonists for smoking cessation.
    Cahill K, Stead LF, Lancaster T.
    Cochrane Database Syst Rev; 2012 Apr 18; (4):CD006103. PubMed ID: 22513936
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia.
    Havard A, Choi SKY, Pearson SA, Chow CK, Tran DT, Filion KB.
    JAMA Netw Open; 2021 Nov 01; 4(11):e2136372. PubMed ID: 34842922
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial.
    Heffner JL, Evins AE, Russ C, Lawrence D, Ayers CR, McRae T, Aubin LS, Krishen A, West R, Anthenelli RM.
    J Affect Disord; 2019 Sep 01; 256():267-277. PubMed ID: 31195244
    [Abstract] [Full Text] [Related]

  • 17. Effects of Combined Varenicline With Nicotine Patch and of Extended Treatment Duration on Smoking Cessation: A Randomized Clinical Trial.
    Baker TB, Piper ME, Smith SS, Bolt DM, Stein JH, Fiore MC.
    JAMA; 2021 Oct 19; 326(15):1485-1493. PubMed ID: 34665204
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR, Varenicline Phase 3 Study Group.
    JAMA; 2006 Jul 05; 296(1):56-63. PubMed ID: 16820547
    [Abstract] [Full Text] [Related]

  • 19. Nicotine receptor partial agonists for smoking cessation.
    Cahill K, Stead LF, Lancaster T.
    Cochrane Database Syst Rev; 2010 Dec 08; (12):CD006103. PubMed ID: 21154363
    [Abstract] [Full Text] [Related]

  • 20. Nicotine receptor partial agonists for smoking cessation.
    Cahill K, Stead LF, Lancaster T.
    Cochrane Database Syst Rev; 2011 Feb 16; (2):CD006103. PubMed ID: 21328282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.